Abstract:Background High-level expression of NAD(P)H: quinoneoxidoreductase 1 (NQO1) has been correlated with many types of human cancers, suggesting that NQO1 plays important roles in tumor occurrence and progression. This study attempted to explore the role of NQO1 in tumor progression and prognostic evaluation of non-small cell lung cancer (NSCLC). Methods Total 164 tissue samples, including 150 NSCLC paired with the adjacent non-tumor tissues and 14 normal lung tissues, were picked-up for immunohistochemical (IHC) staining of the NQO1 protein, and immunofluorescence (IF) staining was also performed to detect the subcellular localization of the NQO1 protein in A549 human lung cancer cells. The correlation between NQO1 expression and clinicopathological characteristics were evaluated by Chi-square test and Fisher’s exact tests. The disease-free survival (DFS) and overall survival (OS) rates of NSCLC patients were calculated by the Kaplan-Meier method, and univariate and multivariate analyses were performed using the Cox proportional hazards regression model. Results The NQO1 protein showed a mainly cytoplasmic staining pattern in lung cancer cells, including adenocarcinoma and squamous cell carcinoma (SCC). Both positive rate and strongly positive rate of NQO1 protein expression were significantly higher in NSCLC (59.3% and 28.0%) than that in adjacent non tumor (8.0% and 1.3%) and normal lung tissues (0%). The positive rate of NQO1 was related with clinical stage and lymph node metastasis, and the strongly positive rate of NQO1 protein was significantly correlated with tumor size, poor differentiation, advanced clinical stage and lymph node metastasis in NSCLC. Additionally, survival analyses showed that the patients with NQO1 positive expression had lower OS rates compared with those with NQO1 negative expression in the groups of T1-2, T3-4, without LN metastasis and stage I-II of NSCLC, respectively; however, in the groups of patients with LN metastasis or III-IV stages, OS rate was not correlated with NQO1 expression status. Moreover, multivariate analysis suggested that NQO1 emerged as a significant independent prognostic factor along with tumor size, differentiation, lymph node metastasis and clinical stage in patients with NSCLC. Conclusions NQO1 is upregulated in NSCLC, and it may be a useful poor prognostic biomarker and a potential therapeutic target for patients with NSCLC.

CXCL14 and NOS1 Expression in Specimens from Patients with Stage I-IIIA Nonsmall Cell Lung Cancer after Curative Resection

Transforming Growth Factor-Β1 and Α-Smooth Muscle Actin in Stromal Fibroblasts Are Associated with a Poor Prognosis in Patients with Clinical Stage I–IIIA Nonsmall Cell Lung Cancer after Curative Resection

Nad(P)H:Quinone Oxidoreductase-1 Overexpression Predicts Poor Prognosis in Small Cell Lung Cancer

The Expression Levels and Prognosis of Notch Family in Ten Cases of Small Cell Lung Cancer

Extracellular matrix expression in non small cell lung cancer and its relationship with neo-adjuvant chemotherapy

[Serum Levels of Endostatin and VEGF in Non-Small Cell Lung Cancer Patients and the Relationship with the Clinical Pathophysiological Characteristics].

Expressions of CLDN1 and Insulin-Like Growth Factor 2 Are Associated with Poor Prognosis in Stage N2 Non-Small Cell Lung Cancer

Expression of CXCL8 and its relationship with prognosis in patients with non-small cell lung cancer

An inter-correlation among chemokine (C-X-C motif) ligand (CXCL) 1, CXCL2 and CXCL8, and their diversified potential as biomarkers for tumor features and survival profiles in non-small cell lung cancer patients

NQO1 protein expression predicts poor prognosis of non-small cell lung cancers

Association Between CXCL16/CXCR6 Expression and the Clinicopathological Features of Patients with Non-Small Cell Lung Cancer.

Expression of VEGFR2 and NRP-1 in Non-Small Cell Lung Cancer and Their Clinical Significance

CXCL5 as a potential novel prognostic factor in early stage non-small cell lung cancer: results of a study of expression levels of 23 genes

Association of Preoperative Neutrophil-to-Lymphocyte Ratio with Clinicopathological Characteristics and Prognosis in Stage I Non-small Cell Lung Cancer

Gene expression levels of CSNK1A1 and AAC-11, but not NME1, in tumor tissues as prognostic factors in NSCLC patients

EGFR and COX-2 protein expression in non-small cell lung cancer and the correlation with clinical features

Forkhead Box N1 is Possibly a Novel Biomarker and Prognostic Indicator for Patients with Squamous Cell Lung Carcinoma

Prognostic Significance of the Combined Score of Endothelial Expression of Nucleolin and CD31 in Surgically Resected Non-Small Cell Lung Cancer

Association of SOX2 and Nestin DNA Amplification and Protein Expression with Clinical Features and Overall Survival in Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis.

Neutrophil expansion defines an immunoinhibitory peripheral and intratumoral inflammatory milieu in resected non-small cell lung cancer: a descriptive analysis of a prospectively immunoprofiled cohort

Expression of Chemokine CXCL14 in Primary Osteosarcoma and Its Association with Prognosis